- Home
- THCH vs ONCY Comparison
THCH vs ONCY Comparison
Compare THCH & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THCH
- ONCY
- Stock Information
- Founded
- THCH 2018
- ONCY 1998
- Country
- THCH China
- ONCY Canada
- Employees
- THCH N/A
- ONCY N/A
- Industry
- THCH Blank Checks
- ONCY Pharmaceuticals and Biotechnology
- Sector
- THCH Finance
- ONCY Health Care
- Exchange
- THCH Nasdaq
- ONCY Nasdaq
- Market Cap
- THCH 84.8M
- ONCY 89.7M
- IPO Year
- THCH N/A
- ONCY 1999
- Fundamental
- Price
- THCH $2.49
- ONCY $1.29
- Analyst Decision
- THCH
- ONCY Strong Buy
- Analyst Count
- THCH 0
- ONCY 5
- Target Price
- THCH N/A
- ONCY $5.00
- AVG Volume (30 Days)
- THCH 22.0K
- ONCY 726.0K
- Earning Date
- THCH 08-26-2025
- ONCY 08-08-2025
- Dividend Yield
- THCH N/A
- ONCY N/A
- EPS Growth
- THCH N/A
- ONCY N/A
- EPS
- THCH N/A
- ONCY N/A
- Revenue
- THCH $187,316,342.00
- ONCY N/A
- Revenue This Year
- THCH N/A
- ONCY N/A
- Revenue Next Year
- THCH N/A
- ONCY N/A
- P/E Ratio
- THCH N/A
- ONCY N/A
- Revenue Growth
- THCH N/A
- ONCY N/A
- 52 Week Low
- THCH $1.95
- ONCY $0.33
- 52 Week High
- THCH $5.15
- ONCY $1.53
- Technical
- Relative Strength Index (RSI)
- THCH 39.96
- ONCY 64.29
- Support Level
- THCH $2.48
- ONCY $1.05
- Resistance Level
- THCH $2.60
- ONCY $1.25
- Average True Range (ATR)
- THCH 0.13
- ONCY 0.09
- MACD
- THCH 0.01
- ONCY 0.02
- Stochastic Oscillator
- THCH 33.70
- ONCY 82.31
About THCH TH International Limited Ordinary shares
TH International Ltd is the parent company of the franchise of Tim Hortons coffee shops and has the rights to operate Tim Hortons coffee shops in mainland China, Hong Kong, and Macau. Through the Tim Hortons brand, the firm offers freshly brewed coffee, tea, and other beverages, bakery & sides, and sandwiches. The Company operated under single reportable segment, Tim Hortons. The company's revenue is derived from its operations in the PRC.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.